Ensuring Robust Data Privacy and Protection: An Overview of the MMS Framework

In today’s digital age, data privacy and protection have become paramount concerns for organizations across various industries. Last year alone, the HIPAA Journal reported that a record-breaking 133 million individuals had their healthcare data compromised across 655 breaches, and new research from this outlet shows that this trend is not slowing down.

This, coupled with regulatory imperatives, means that implementing stringent data protection measures is crucial for maintaining the highest standards of information security.

Information Security Management System (ISMS) explained!

A robust Information Security Management System (ISMS) is essential for maintaining high levels of data security and protection needed in today’s healthcare and pharmaceutical landscape. An organization, like MMS, that is certified to the ISO 27001:2022 standard underscores an organization’s commitment to information security. This encompasses various security capabilities and controls designed to protect sensitive data.

Key components of the ISMS, include the following:

  • Physical and Logical Security Standards: Adhering to ISO 27001-compliant physical and logical security standards is crucial. These standards include multiple layers of information security and data protection, from firewall and intrusion prevention systems to real-time virus, malware, and phishing protection.
  • Ongoing Education and Training: Continuous education and communication to all stakeholders in an organization are critical components of a security strategy like this one. Conducting phishing simulations and training raises awareness among employees about potential cyber threats should occur regularly and unexpectedly.
  • Multi-Factor Authentication (MFA) and Device Registration: Implementing MFA and device registration for accessing cloud services, including SharePoint Online, OneDrive, Exchange Online (Email), and VPN, ensures that only authorized personnel can access sensitive information.
  • Redundancy and Fault Tolerance: Employing redundancy and fault tolerance mechanisms across servers, networks, and internet access points ensures business continuity. This includes real-time server, application, network, and access event monitoring.
  • Business Continuity and Disaster Recovery: A robust business continuity and disaster recovery process is essential. This includes secure data exchange policies and tools, as well as backup and restore capabilities to support all services and client deliverables. For the ISMS, include the following:

Management of Protected Health Information

Protecting and managing protected health information (PHI) requires well-defined standard operating procedures (SOP). Recently completing an ISO audit with no findings or necessary remediations, MMS has employed an SOP titled “QA-SOP-016 Protection of Private Data and Privacy Breach Management.”

Within, this SOP outlines the processes for safeguarding private data and managing privacy breaches. Additionally, it provides employees with the proper resources needed to respond to Sponsor inquiries regarding privacy policies and data management practices.

In response to the European Court of Justice’s Schrems II ruling, MMS has successfully completed the self-certification process for the EU-US Data Privacy Framework (EU-US DPF), with an updated Privacy Policy and Privacy Notice and the company is now in the active list of certified companies for Data Privacy Framework. This certification ensures that MMS complies with the EU-US DPF, the UK Extension to the EU-US DPF, and the Swiss-US DPF, facilitating reliable personal data transfers between the US and the EU, UK, and Switzerland.

The dedication of MMS and its colleagues to data privacy and protection for Sponsors, patients, and people across the globe is evident. A comprehensive information security framework and adherence to international standards is a must for every CRO in this everchanging pharmaceutical industry. By continually enhancing its security measures and compliance practices, MMS ensures the highest level of data protection to keep us focused on what is most important – positively improving lives worldwide.

Authored by: Seetharaman Sankaran, Associate Director, IT, Quality and Compliance

Suggested For You

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives

September 24th, 2024

Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry

perspectives

September 11th, 2024

From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

perspectives

September 4th, 2024

Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders

perspectives

August 27th, 2024

Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs

perspectives

August 20th, 2024

Clinical Study Protocols: A Comprehensive Guide to Best Practices From A Senior Medical Writer

perspectives

August 13th, 2024

How To Navigate The Nonclinical Evaluation Landscape Of Biopharmaceuticals

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

perspectives

July 16th, 2024

Key Steps to Successful CMC Authoring of IND and IMPD Submissions

perspectives

July 9th, 2024

Managing RTOR Submissions: How to Run a Successful Race from the Top Line Starting Line